Publication | Closed Access

Pembrolizumab and platinum-based chemotherapy as first-line therapy for advanced non–small-cell lung cancer: Phase 1 cohorts from the KEYNOTE-021 study

MedicinePathologyImmune Checkpoint InhibitorKeynote-021 StudyCancer TreatmentOncologyRadiation OncologyPhase 1Lung CancerPlatinum-based Chemotherapy